Mesenchymal Stem Cells as Promoters, Enhancers, and Playmakers of the Translational Regenerative Medicine-Reference-Cited by-同舟云学术

Mesenchymal Stem Cells as Promoters, Enhancers, and Playmakers of the Translational Regenerative Medicine

Published:2017 Issue: Volume:2017 Page:1-2
ISSN:1687-966X
Container-title:Stem Cells International
language:en
Short-container-title:Stem Cells International

Author:

Ballini Andrea¹^ORCID,Scacco Salvatore¹,Coletti Dario²^ORCID,Pluchino Stefano³,Tatullo Marco⁴^ORCID

Affiliation:

1. Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari “Aldo Moro”, Bari, Italy

2. Institut de Biologie-Biology of Adaptation and Aging (B2A), Université Pierre et Marie Curie Paris 6, Paris, France

3. Department of Clinical Neurosciences-Division of Stem Cell Neurobiology, Wellcome Trust-Medical Research Council Stem Cell Institute and NIHR Biomedical Research Centre, University of Cambridge, Cambridge, UK

4. Biomedical Section, Tecnologica Research Institute, Crotone, Italy

Publisher

Hindawi Limited

Subject

Cell Biology,Molecular Biology

Link

http://downloads.hindawi.com/journals/sci/2017/3292810.pdf

Reference13 articles.

1. STROMAL CELLS RESPONSIBLE FOR TRANSFERRING THE MICROENVIRONMENT OF THE HEMOPOIETIC TISSUES

2. Mesenchymal Stem Cells as Therapeutics

3. Clinical-scale expansion of mesenchymal stromal cells: a large banking experience

4. International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials

5. Potency testing of mesenchymal stromal cell growth expanded in human platelet lysate from different human tissues

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The reprotoxic adverse side effects of neurogenic and neuroprotective drugs: current use of human organoid modeling as a potential alternative to preclinical models;Frontiers in Pharmacology;2024-06-14

2. Current and Future Trends in Orthopedics;Managing Cardiovascular Risk In Elective Total Joint Arthroplasty;2023

3. Mesenchymal Stem Cells Derived from Umbilical Cord Blood Having Excellent Stemness Properties with Therapeutic Benefits - a New Era in Cancer Treatment;Current Stem Cell Research & Therapy;2022-08-02

4. The Comparison of the Differentiation Potential of Periodontal Ligament and Dental Pulp Mesenchymal Stem Cells in the Inflammatory Synovium Microenvironment;Cyprus Journal of Medical Sciences;2022-06-01

5. Phenytoin Is Promoting the Differentiation of Dental Pulp Stem Cells into the Direction of Odontogenesis/Osteogenesis by Activating BMP4/Smad Pathway;Disease Markers;2022-04-21